MedTrace Logo

Role of Inhaler Adherence and Blood Eosinophil Count in Exacerbations of COPD

NCT05814484 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 104

Last updated 2023-07-19

No results posted yet for this study

Summary

This is an observational study examining inhaler adherence and subsequent changes in blood eosinophil count in exacerbations of Chronic obstructive pulmonary disease (COPD) population.

The study will run for 6 months as an observation period. Passive inhaler adherence monitoring will be done electronically via inhaler sensors connected to mobile Apps, and collecting symptoms questionnaires, diary of exacerbation events and trial visits predominantly in remote fashion. It will explore the feasibility of digital platform in clinical practice to collect the adherence data along with exacerbation events.

Conditions

Sponsors & Collaborators

  • Aparito Ltd.

    collaborator INDUSTRY

  • University of Leicester

    lead OTHER

Principal Investigators

  • Neil Greening · University of Leicester, Biomedical Research Centre, Respiratory Science

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-10
Primary Completion
2024-11-30
Completion
2025-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05814484 on ClinicalTrials.gov